An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis

Osteoporosis International

Volumn 22, Issue 1, 2011, Pages 305-315

  Caplan, L ^a,b   Hines, A E ^a   Williams, E ^a   Prochazka, A V ^a,b   Saag, K G ^c   Cunningham, F ^d   Hutt, E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Veterans Affairs Pharmacy Benefits Management   (United States)

Author keywords

Adverse effects; Glucocorticoids; Osteoporosis; Prevention

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GONADORELIN AGONIST; HEPARIN; LOOP DIURETIC AGENT; METHYLPREDNISOLONE; PARATHYROID HORMONE[1-34]; PREDNISOLONE; PREDNISONE; RALOXIFENE; TESTOSTERONE; THYROID HORMONE; VITAMIN D;

ADULT; ALCOHOL ABUSE; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG CAPSULE; FEMUR FRACTURE; FRACTURE; GASTROINTESTINAL DISEASE; HUMAN; HYPERCALCIURIA; HYPERPARATHYROIDISM; HYPOGONADISM; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY FAILURE; LIVER DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MEN'S HEALTH; MULTIVARIATE ANALYSIS; NEOPLASM; NEPHROLITHIASIS; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT CODING; PERNICIOUS ANEMIA; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; SPINAL CORD INJURY; STEROID THERAPY; TABLET; TREATMENT OUTCOME; VERTEBRA FRACTURE; VETERAN;

AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PATIENT SELECTION; RISK FACTORS;

EID: 78651497081     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1201-x     Document Type: Article

References (52)

1. LJ Melton III 1995 How many women have osteoporosis now? J Bone Miner Res 10 175 177 10.1002/jbmr.5650100202 7754796
2. TP Van Staa HG Leufkens L Abenhaim B Begaud B Zhang C Cooper 2000 Use of oral corticosteroids in the United Kingdom QJM 93 105 111 10.1093/qjmed/93.2.105 10700481
3. TP Van Staa HG Leufkens L Abenhaim B Zhang C Cooper 2000 Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993 1000 10.1359/jbmr.2000.15.6.993 10841167
4. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis 2001 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update Arthritis Rheum 44 1496 1503 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5
5. RA Adler MC Hochberg 2003 Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs Arch Intern Med 163 2619 2624 10.1001/archinte.163.21.2619 14638562
6. JE Compston 2007 Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis Curr Rheumatol Rep 9 78 84 1:CAS:528:DC%2BD2sXhtVentbbI 10.1007/s11926-007-0026-x 17437672
7. JD Adachi WP Olszynski DA Hanley AB Hodsman DL Kendler KG Siminoski J Brown EA Cowden D Goltzman G Ioannidis RG Josse LG Ste-Marie AM Tenenhouse KS Davison KL Blocka AP Pollock J Sibley 2000 Management of corticosteroid-induced osteoporosis Semin Arthritis Rheum 29 228 251 1:CAS:528:DC%2BD3cXhsF2lsLw%3D 10.1016/S0049-0172(00)80011-6 10707991
8. PN Sambrook T Diamond L Ferris M Fiatarone-Singh L Flicker A MacLennan C Nowson S O'Neill H Greville 2001 Corticosteroid induced osteoporosis. Guidelines for treatment Aust Fam Physician 30 793 796 1:STN:280:DC%2BD3MrnsVSqsA%3D%3D 11681155
9. H Nawata S Soen R Takayanagi I Tanaka K Takaoka M Fukunaga T Matsumoto Y Suzuki H Tanaka S Fujiwara T Miki A Sagawa Y Nishizawa Y Seino 2005 Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004) J Bone Miner Metab 23 105 109 10.1007/s00774-004-0596-x 15750687
10. JP Devogelaer S Goemaere S Boonen JJ Body JM Kaufman JY Reginster S Rozenberg Y Boutsen 2006 Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club Osteoporos Int 17 8 19 1:CAS:528:DC%2BD2MXhtlWkt7rK 10.1007/s00198-005-2032-z 16217586
11. PP Geusens WF Lems HJ Verhaar G Leusink S Goemaere H Zmierczack J Compston 2006 Review and evaluation of the Dutch guidelines for osteoporosis J Eval Clin Pract 12 539 548 10.1111/j.1365-2753.2006.00647.x 16987116
12. B Ettinger P Chidambaran A Pressman 2001 Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs Am J Manag Care 7 597 605 1:STN:280:DC%2BD3Mzos1CmsA%3D%3D 11439733
13. LM Buckley M Marquez JO Hudson RW Downs P Vacek RE Small R Poses 1998 Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty J Rheumatol 25 2195 2202 1:STN:280:DyaK1M%2Fjtl2ksQ%3D%3D 9818664
14. KG Saag SH Gehlbach JR Curtis TE Youket K Worley JL Lange 2006 Trends in prevention of glucocorticoid-induced osteoporosis J Rheumatol 33 1651 1657 16845707
15. DH Solomon JN Katz JP Jacobs AM La Tourette J Coblyn 2002 Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice Arthritis Rheum 46 3136 3142 10.1002/art.10613 12483716
16. ME Elliott RM Farrah NC Binkley ML Carnes A Gudmundsson 2000 Management of glucocorticoid-induced osteoporosis in male veterans Ann Pharmacother 34 1380 1384 1:STN:280:DC%2BD3M7jslCrsg%3D%3D 11144692
17. AC Feldstein PJ Elmer GA Nichols M Herson 2005 Practice patterns in patients at risk for glucocorticoid-induced osteoporosis Osteoporos Int 16 2168 2174 1:CAS:528:DC%2BD2MXhtlWkt73K 10.1007/s00198-005-2016-z 16142501
18. DH Solomon JN Katz AM La Tourette JS Coblyn 2004 Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial Arthritis Rheum 51 383 387 1:CAS:528:DC%2BD2cXls1Sjtrw%3D 10.1002/art.20403 15188323
19. JR Curtis AO Westfall J Allison A Becker ME Melton A Freeman CI Kiefe M MacArthur T Ockershausen E Stewart N Weissman KG Saag 2007 Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial Arch Intern Med 167 591 596 10.1001/archinte.167. 6.591 17389291
20. MM Chitre W Hayes 2008 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan J Manag Care Pharm 14 281 290 18439050
21. EM Aagaard P Lin GW Modin NE Lane 1999 Prevention of glucocorticoid- induced osteoporosis: provider practice at an urban county hospital Am J Med 107 456 460 1:STN:280:DC%2BD3c%2FjsVGrug%3D%3D 10.1016/S0002-9343(99)00265-X 10569300
22. A Mudano J Allison J Hill T Rothermel K Saag 2001 Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort J Rheumatol 28 1298 1305 1:STN:280:DC%2BD38%2Fht1ehsA%3D%3D 11409123
23. M Duyvendak M Naunton J Atthobari PB van den Berg JR Brouwers 2007 Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005 Osteoporos Int 18 1429 1433 1:STN:280: DC%2BD2srjtVSjtw%3D%3D 10.1007/s00198-007-0345-9 17323108
24. JA Singh AR Holmgren S Noorbaloochi 2004 Accuracy of veterans Administration databases for a diagnosis of rheumatoid arthritis Arthritis Rheum 51 952 957 10.1002/art.20827 15593102
25. JR Curtis AO Westfall JJ Allison A Freeman KG Saag 2006 Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users Osteoporos Int 17 1268 1274 1:CAS:528:DC%2BD28XmsFOmt7o%3D 10.1007/s00198-006- 0136-8 16724286
26. TP Van Staa HG Leufkens C Cooper 2002 The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis Osteoporos Int 13 777 787 10.1007/s001980200108 12378366
27. Shekelle P, Munjas B, Liu H, Paige N, Zhou A (2007) Screening men for osteoporosis: who & how. Department of Veterans Affairs (HSR&D Evidence Synthesis Pilot Program), Washington, DC
28. Chrousos GP (2001) Glucocorticoid therapy. In: Felig P, Frohman L (eds) Endocrinology and metabolism, 4th edn, Chap 14. McGraw-Hill, New York, pp 609-632
29. TR Mikuls KG Saag V George AS Mudano S Banerjee 2005 Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture J Rheumatol 32 870 875 15868624
30. LM Cruse J Valeriano FB Vasey JD Carter 2006 Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men J Clin Rheumatol 12 221 225 10.1097/01.rhu.0000242778.65766.22 17023807
31. S Schneeweiss JD Seeger M Maclure PS Wang J Avorn RJ Glynn 2001 Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data Am J Epidemiol 154 854 864 1:STN:280: DC%2BD3MnktlSguw%3D%3D 10.1093/aje/154.9.854 11682368
32. S Schneeweiss PS Wang J Avorn RJ Glynn 2003 Improved comorbidity adjustment for predicting mortality in Medicare populations Health Serv Res 38 1103 1120 10.1111/1475-6773.00165 12968819
33. V Elliot-Gibson ER Bogoch SA Jamal DE Beaton 2004 Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review Osteoporos Int 15 767 778 1:STN:280:DC%2BD2cvlvFGntQ%3D%3D 10.1007/s00198-004-1675-5 15258724
34. AM Tromp ME Ooms C Popp-Snijders JC Roos P Lips 2000 Predictors of fractures in elderly women Osteoporos Int 11 134 140 1:STN:280: DC%2BD3c3lsVensw%3D%3D 10.1007/PL00004174 10793871
35. SJ Petty TJ O'Brien JD Wark 2007 Anti-epileptic medication and bone health Osteoporos Int 18 129 142 1:STN:280:DC%2BD2s%2FitVWmuw%3D%3D 10.1007/s00198-006-0185-z 17091219
36. MC Sheppard R Holder JA Franklyn 2002 Levothyroxine treatment and occurrence of fracture of the hip Arch Intern Med 162 338 343 1:CAS:528:DC%2BD38XitVGgu78%3D 10.1001/archinte.162.3.338 11822927
37. B Mezuk WW Eaton SH Golden 2008 Depression and osteoporosis: epidemiology and potential mediating pathways Osteoporos Int 19 1 12 1:STN:280: DC%2BD2sjgvV2hsQ%3D%3D 10.1007/s00198-007-0449-2 17763997
38. P Vestergaard 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis Osteoporos Int 18 427 444 1:STN:280:DC%2BD2s7jtVCltw%3D%3D 10.1007/s00198-006-0253-4 17068657
39. F Saad JD Adachi JP Brown LA Canning KA Gelmon RG Josse KI Pritchard 2008 Cancer treatment-induced bone loss in breast and prostate cancer J Clin Oncol 26 5465 5476 10.1200/JCO.2008.18.4184 18955443
40. LJ Melton III RA Kyle SJ Achenbach AL Oberg SV Rajkumar 2005 Fracture risk with multiple myeloma: a population-based study J Bone Miner Res 20 487 493 10.1359/JBMR.041131 15746994
41. KM Berg HV Kunins JL Jackson S Nahvi A Chaudhry KA Harris Jr R Malik JH Arnsten 2008 Association between alcohol consumption and both osteoporotic fracture and bone density Am J Med 121 406 418 1:CAS:528:DC%2BD1cXlsFGis7o%3D 10.1016/j.amjmed.2007.12.012 18456037
42. J Cunningham SM Sprague J Cannata-Andia M Coco M Cohen-Solal L Fitzpatrick D Goltzmann MH Lafage-Proust M Leonard S Ott M Rodriguez C Stehman-Breen P Stern J Weisinger 2004 Osteoporosis in chronic kidney disease Am J Kidney Dis 43 566 571 10.1053/j.ajkd.2003.12.004 14981616
43. A Gal-Moscovici SM Sprague 2007 Osteoporosis and chronic kidney disease Semin Dial 20 423 430 10.1111/j.1525-139X.2007.00319.x 17897249
44. C Trautwein M Possienke HJ Schlitt KH Boker R Horn R Raab MP Manns G Brabant 2000 Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation Am J Gastroenterol 95 2343 2351 1:CAS:528:DC%2BD3cXntFCmt74%3D 10.1111/j.1572-0241. 2000.02269.x 11007240
45. A Mounach Z Ouzzif G Wariaghli L Achemlal I Benbaghdadi A Aouragh A Bezza MA El 2008 Primary biliary cirrhosis and osteoporosis: a case-control study J Bone Miner Metab 26 379 384 10.1007/s00774-007-0833-1 18600405
46. S Perreault A Dragomir A Desgagne L Blais M Rossignol J Blouin Y Moride LG Ste-Marie JC Fernandes 2005 Trends and determinants of antiresorptive drug use for osteoporosis among elderly women Pharmacoepidemiol Drug Saf 14 685 695 1:CAS:528:DC%2BD2MXhtFygsrzJ 10.1002/pds.1068 15645517
47. MD Cabana CS Rand NR Powe AW Wu MH Wilson PA Abboud HR Rubin 1999 Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1458 1465 1:STN:280:DC%2BD3c%2FgsVSqtw%3D%3D 10.1001/jama.282.15.1458 10535437
48. A Alexopoulou SP Dourakis D Mantzoukis T Pitsariotis A Kandyli M Deutsch AJ Archimandritis 2008 Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece Eur J Intern Med 19 505 510 10.1016/j.ejim.2007.06.030 19013378
49. HL Liao JT Chen TC Ma YS Chang 2008 Analysis of drug-drug interactions (DDIs) in nursing homes in Central Taiwan Arch Gerontol Geriatr 47 99 107 10.1016/j.archger.2007.06.007 17868936
50. AJ Perkins K Kroenke J Unutzer W Katon JW Williams C Hope CM Callahan 2004 Common comorbidity scales were similar in their ability to predict health care costs and mortality J Clin Epidemiol 57 1040 1048 10.1016/j.jclinepi.2004. 03.002 15528055
51. JT Lurk DJ DeJong TM Woods ME Knell CA Carroll 2004 Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting Am J Health Syst Pharm 61 267 272 14986557
52. X Li D Guh D Lacaille J Esdaile AH Anis 2007 The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities Health Policy 82 340 347 10.1016/j.healthpol. 2006.11.002 17134787